Invitrogen™ Rat p53 ELISA Kit

Ref.: BL-RE-092088Manufacturer ref.: ERA47RBX5 5 x 96 tests
€2,950.00 excl. VAT

Rat p53 quantitates rat p53 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat p53.

Accession number
Antigène NY-CO-13 ; bbl ; BCC7 ; BFY ; bhy ; Antigène tumoral cellulaire p53; Cys 51 Stop; EGK_08142; FLJ92943; HGNC11998; I79_002739; LFS1; syndrome de Li-Fraumeni; mutant p53; protéine tumorale mutante 53; OTTMUSP00000006194; p44; P53; antigène tumoral cellulaire p53; suppresseur de tumeur p53; phosphoprotéine p53; protéine P53; Tp53; tp53.L; protéine liée à la transformation 53; protéine liée à la transformation 53; protéine Trp248; protéine TRP53; protéine liée à la transformation Protéine tumorale p53; protéine tumorale p53 (syndrome de Li-Fraumeni); protéine tumorale p53 L homeolog; suppresseur de tumeur p53; suppresseur de tumeur p53 phosphoprotéine; protéine suppresseur de tumeur p53; suppresseur de tumeur p53; protéine tumorale p53; XELAEV_180196761mg; Xp53; Xrel3
Dose range
0.328 to 80 ng/ml
Sensitivity of the dosage
0.32 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Rat p53 quantitates rat p53 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat p53.

Rat p53 quantitates rat p53 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat p53.

The tumour suppressant protein, p53, is a sequence-specific transcription factor that is activated by cell stress. P53 allows to mediate cell cycle arrest or apoptosis in response to damage to the DNA or to the deprivation of pyrimidine nucleotides. P53 is regulated in response to stress signals and stimulated to activate transcription of specific genes, resulting in the expression of p21waf1 and other proteins involved in G1 or G2/M shutdown. The p53 structure includes a N-terminal end transactivation domain, a central DNA binding domain, a domain of oligomerization and a regulatory domain of the C-terminal end. There are various p53 phosphorylation sites, including Ser15 phosphorylation, which is important for p53 activation and stabilization. P53 was characterized as a factor in blocking the proliferative action of damaged cells and acting as an anticancer agent. The phosphorylation of Ser392 in p53 has been shown to be related to the formation of human tumours. In addition, it was shown that p53 protein was related to the effects of aging and oxidative stress and that an increase of p53 was related to long-term potentiation deficits (PLT) in learning and memory. P53 is found in very small amounts in normal cells, however, in a variety of transformed cell lines, it is expressed in high quantities and appears to contribute to transformation and malignancy. P53 mutants that occur frequently in a number of human cancers do not bind the consensus sequence binding site of the DNA and cause loss of tumour suppressant activity. Alterations of the TP53 gene occur not only in the form of somatic mutations in human malignancies, but also in the form of germ mutations in certain cancer-prone families such as Li-Fraumeni syndrome.

Sensitivity

Sensitivity of the dosage: 0.32 ng/ml.

Measurement range

Dose range: 0.328 to 80 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: p53.

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17115889
Specifications
Accession numberAntigen NY-CO-13; bbl; BCC7; BFY; bhy; Cellular tumour antigen p53; Cys 51 Stop; EGK_08142; FLJ92943; HGNC11998; I79_002739; LFS1; Li-Fraumeni syndrome; mutant p53; mutant tumour protein 53; OTTMUSP00000006194; p44; P53; cell tumour antigen p53; tumour suppressor p53; ph
Dose range0.328 to 80 ng/ml
Sensitivity of the dosage0.32 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P10361
Gene symbol(s)Tp53
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
Targetp53
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; plasma, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ERA47RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.